lenalidomide has been researched along with Angiomatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, Z; Hájek, R; Koukalová, R; Král, Z; Krejčí, M; Křikavová, L; Matýšková, M; Mayer, J; Navrátil, M; Nebeský, T; Neuman, C; Pour, L; Rehák, Z; Szturz, P; Tomíška, M | 1 |
1 other study(ies) available for lenalidomide and Angiomatosis
| Article | Year |
|---|---|
[Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].
Topics: Adult; Angiogenesis Inhibitors; Angiomatosis; Biomarkers; Disseminated Intravascular Coagulation; Humans; Interferon-alpha; Lenalidomide; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Thalidomide; Tomography, X-Ray Computed | 2012 |